ASSOCIATION OF SLEEP DURATION WITH COGNITION AND VASCULAR BRAIN INJURY MODERATED BY HYPERTENSIVE STATUS High blood pressure and shorter sleep may worsen brain decline: study
With
Dr Stephanie Yiallourou, Senior Research Fellow
Turner Institute for Brain & Mental Health, Monash University
Melbourne, Australia
Associate Professor Matthew Pase
Turner Institute for Brain & Mental Health, Monash University
Melbourne, Australia
CASE STUDY
Filmed in Melbourne, Australia| May 2025
People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found.
Published in the Journal of the American Heart Association, researchers assessed whether the combined effect of hypertension and short sleep duration had a negative impact on brain health.
They used data from 682 dementia-free Framingham Heart Study participants who completed overnight sleep recordings, self-reported sleep duration questionnaires, blood pressure and cognitive assessments; 637 underwent brain magnetic resonance imaging (MRI).
In those with high blood pressure, shorter sleep duration was associated with poorer executive functioning and markers of brain injury and accelerated brain ageing on MRI. These associations were not observed in people with normal blood pressure.
These results were similar following adjustment for genetic, clinical and demographic variables.
Insufficient sleep is generally defined as less than seven hours. Participants reported sleeping an average of seven hours per night, with 32 percent reporting a short sleep duration of less than six hours per night.
Moderate to severe obstructive sleep apnoea was identified in 16 per cent of individuals, and almost one‐quarter of the overall sample reported using sleeping pills regularly.
“In individuals with hypertension, shorter sleep duration was associated with worse cognitive performance and greater brain injury,” the study found.
“Inadequate sleep has been linked to hypertension and dementia, and though the underlying mechanisms remain unclear, it is possible that short sleep and hypertension interact to increase the risk of cognitive impairment and vascular brain injury.”
While the cohort was based in the US, researchers believe the results would be similar in Australia.
Senior author Associate Professor Matthew Pase, from the Monash University School of Psychological Sciences and Turner Institute for Brain and Mental Health, said short sleep duration was already associated with an increased risk of cognitive impairment and dementia.
He said while short sleep was associated with elevated blood pressure, the combination of short sleep and hypertension on brain health was unclear before this study.
“These findings have significance, given that over one-third of Australians experience sleep problems,” Associate Professor Pase said. “Importantly, sleep problems and hypertension are treatable. Addressing these factors may offer new opportunities for intervention to improve brain health.”
First author Dr Stephanie Yiallourou, from the Monash University School of Psychological Sciences and Turner Institute for Brain and Mental Health, said screening people with high blood pressure for insufficient sleep could allow tailored therapies to improve brain aging and reduce brain injury.
Dr Yiallourou said they could also be targeted for new randomised controlled trials to determine the efficacy of sleep treatments and blood pressure–lowering therapies in preventing or delaying cognitive impairment.
“The next step in this research is to explore whether the double hit of short sleep and hypertension is associated with dementia risk in the long-term,” she said.
This work was supported by an Alzheimer’s Association Grant.
Source: Monash University Media Release
-
Non-invasive tools for CVD screening and monitoring
Dr Hadi Afsharan is a Research Fellow Cardiovascular Science & Diabetes at the Harry Perkins Institute of Medical Research; is a translational research and innovation fellow in medical technologies at The University of Western Australia, holding dual titles as Translational Fellow and Innovation Fellow within UWA’s Medical School and the FHRI (Future Health Research and Innovation) program.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
-
Risk factors and prevention of respiratory infections and infectious diseases in children
A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Co-Head of the Infectious Disease Epidemiology team within the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia and Associate Professor at the School of Population Health, Curtin University in Western Australia.
A/Prof Moore has been awarded more than $19M in competitive research grants, co-authored more than 140 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.
